P-15 vs Ac-SDKP
Head-to-head comparison of P-15 (Synthetic Collagen Type I Cell-Binding Peptide (P-15)) and Ac-SDKP (N-Acetyl-Seryl-Aspartyl-Lysyl-Proline) — benefits, dosing, side effects, research data, and where to buy.
| Property | P-15 | Ac-SDKP |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Synthetic Collagen Type I Cell-Binding Peptide (P-15) | N-Acetyl-Seryl-Aspartyl-Lysyl-Proline |
| Molecular Weight | 1500 Da | 432.4 Da |
| Half-Life | N/A | minutes |
| Amino Acids | 15 | 4 |
| Typical Dose | device-dependent local loading | 10–100 µg/kg/day in pre-clinical studies |
| Route | Local/Implant | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 150 | 180 |
| Research Status | Clinical | Pre-clinical |
P-15 Benefits
- ✓improves osteoblast attachment
- ✓supports scaffold osteointegration
- ✓enhances bone fill
- ✓may aid periodontal regeneration
Ac-SDKP Benefits
- ✓anti-inflammatory tissue remodeling
- ✓fibroblast modulation
- ✓microvascular protection
- ✓faster regenerative signaling
P-15 Dosing
embedded in scaffold or graft material|local application|single procedural exposure
Ac-SDKP Dosing
Research-only systemic microdoses|short daily dosing in animal models|route varies by study
P-15 Side Effects
- ⚠local irritation
- ⚠inflammation
- ⚠hypersensitivity
Ac-SDKP Side Effects
- ⚠GI upset
- ⚠hypotension at high exposure
- ⚠unknown long-term safety
Research Overview
P-15
P-15 is a real literature-backed peptide used to improve biomaterial performance in bone repair settings. Most of the evidence is device- or scaffold-based rather than as a free systemic peptide.
Ac-SDKP
Ac-SDKP has literature in tissue remodeling, angiogenesis, and organ repair models. Its strongest evidence is pre-clinical, where it modulates inflammation and fibrosis during healing.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.